Form D · Biotechnology
TAMIR BIOTECHNOLOGY, INC.
Short Hills, NJ · CIK 0000708717
Offering snapshot reported Jan 25, 2018 · SEC filing
- Reported sold
- $809K Offering amount: $1.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 11, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2018 | Initial | $808,638 | No comparison | 3 | SEC filing |
| Dec 30, 2016 | Amendment | $1,722,476 | $197,498vs May 20, 2016 | 9 | SEC filing |
| May 20, 2016 | Initial | $1,524,978 | No comparison | 8 | SEC filing |
| Sep 10, 2015 | Initial | $800,000 | No comparison | 7 | SEC filing |
| May 19, 2014 | Amendment | $850,312 | $100,001vs May 7, 2014 | 9 | SEC filing |
| May 7, 2014 | Initial | $750,311 | No comparison | 9 | SEC filing |
| Oct 4, 2013 | Initial | $5,000 | No comparison | 1 | SEC filing |
| Dec 27, 2012 | Initial | $1,000,000 | No comparison | 5 | SEC filing |
| Nov 2, 2009 | Initial | $3,250,000 | No comparison | 8 | SEC filing |
| May 18, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-304146
Issuance of Convertible Promissory Notes.
Source: Form D, filed Jan 25, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joanne Barsa | Executive |
| John Brancaccio | Director |
| Stephen K. Carter | Director |
| Donald R. Conklin | Director |
| Lawrence A. Kenyon | Executive |
| Fred Knoll | Director |
| Charles Muniz | Director |
| Patrick Ostronic | Director |
| Patrick Ostronick | Director |
| Kuslima Shogen | Director |
| David Sidrandky | Director |
| David Sidransky | Director |
| Jamie Sulley | Director, Executive |
| Jamie Sully | Director, Executive |
| Paul Weiss | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
51 Jfk Parkway, 1 St Floor West, Ste 108
Short Hills, NJ, 07078
Short Hills, NJ, 07078